Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Caroline Scholtes"'
Autor:
Florence Micas, Vanessa Suin, Jean-Marie Péron, Caroline Scholtes, Edouard Tuaillon, Thomas Vanwolleghem, Laurence Bocket, Sébastien Lhomme, Chloé Dimeglio, Jacques Izopet, Florence Abravanel
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
Hepatitis E virus (HEV) genotypes 3 and 4 are the major causes of acute hepatitis in industrialized countries. Genotype 3 is mainly found in Europe and America, while genotype 4 is predominant in Asia. Several Japanese studies have suggested that gen
Externí odkaz:
https://doaj.org/article/5cac5615b5e548a5b935c687906270bc
Autor:
Vinca Icard, Olivier Diaz, Caroline Scholtes, Laure Perrin-Cocon, Christophe Ramière, Ralf Bartenschlager, Francois Penin, Vincent Lotteau, Patrice André
Publikováno v:
PLoS ONE, Vol 4, Iss 1, p e4233 (2009)
The density of circulating hepatitis C virus (HCV) particles in the blood of chronically infected patients is very heterogeneous. The very low density of some particles has been attributed to an association of the virus with apolipoprotein B (apoB) p
Externí odkaz:
https://doaj.org/article/137359f19e2c4e439a6b087bf4e20faa
Autor:
Maria Paola Anolli, Elisabetta Degasperi, Lena Allweiss, Angelo Sangiovanni, Marco Maggioni, Caroline Scholtes, Valerie Oberhardt, Christoph Neumann-Haefelin, Maura Dandri, Fabien Zoulim, Pietro Lampertico
Publikováno v:
Journal of Hepatology. 78:876-880
Autor:
Elisabetta Degasperi, Maria Paola Anolli, Sara Colonia Uceda Renteria, Dana Sambarino, Marta Borghi, Riccardo Perbellini, Caroline Scholtes, Floriana Facchetti, Alessandro Loglio, Sara Monico, Mirella Fraquelli, Andrea Costantino, Ferruccio Ceriotti, Fabien Zoulim, Pietro Lampertico
Publikováno v:
Journal of Hepatology. 77:1525-1531
Bulevirtide (BLV) has recently been conditionally approved for the treatment of chronic hepatitis delta (CHD) in Europe, but its effectiveness and safety in patients with compensated cirrhosis and clinically significant portal hypertension (CSPH) are
Autor:
Caroline Charre, Hadrien Regue, Paul Dény, Laurence Josset, Isabelle Chemin, Fabien Zoulim, Caroline Scholtes
Publikováno v:
Journal of Medical Virology. 95
Autor:
Elena Trombetta, Marta Borghi, Antonio Bertoletti, Maria Manunta, E. Farina, Christine Y.L. Tham, Alessandro Rimondi, Fabien Zoulim, Alessandro Loglio, Riccardo Perbellini, Pietro Lampertico, Caroline Scholtes, Florian van Bömmel, Peter Ferenci, Sara Colonia Uceda Renteria, Heidemarie Holzmann, Ferruccio Ceriotti, Laura Porretti, Daniele Prati
Publikováno v:
Journal of Hepatology. 76:464-469
The entry-inhibitor Bulevirtide (BLV) received conditional approval by EMA in July 2020 for the treatment of adult patients with compensated chronic hepatitis Delta. However, the effectiveness and safety of BLV administered as monotherapy beyond 48 w
Autor:
Helene Fontaine, Claire Fougerou-Leurent, Emmanuel Gordien, Caroline Scholtes, Sophie Metivier, Victor de Lédinghen, Vlad Ratziu, Laurent Alric, Nathalie Ganne-Carrié, Veronique Loustaud-Ratti, Dominique Guyader, Vincent Leroy, Jérôme Dumortier, Karine Lacombe, Georges-Philippe Pageaux, Anne Minello Franza, Christelle Tual, Alain Renault, Estelle Le Pabic, Lucie Marchand, Dominique Roulot, Fabien Zoulim
Publikováno v:
Journal of Hepatology
Journal of Hepatology, 2022, 77, pp.S72-S72
Journal of Hepatology, 2022, 77, pp.S72-S72
International audience; Real life study of bulevirtide in chronic hepatitis delta: preliminary results of the ANRS HD EP01 BuleDelta prospective cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ac49cd156a27f2ffd3f7e24864c65a4
https://hal.science/hal-03770282
https://hal.science/hal-03770282
Autor:
Houcine, Neffati, Jacques, Ritter, Salma, Feki, Anne-Gaëlle, Dron, Amin, Slim, Mohsen, Hassine, Hamadi, Braham, Christophe, Ramiere, Patrice, Andre, Mahjoub, Aouni, Caroline, Scholtes
Publikováno v:
In Clinical Microbiology and Infection May 2012 18(5):E119-E121
Autor:
Victor de Lédinghen, Claire Fougerou-Leurent, Estelle Le Pabic, Stanislas Pol, Dulce Alfaiate, Karine Lacombe, Marie-Noëlle Hilleret, Caroline Lascoux-Combe, Anne Minello, Eric Billaud, Isabelle Rosa, Anne Gervais, Vlad Ratziu, Nathalie Ganne, Georges-Philippe Pageaux, Vincent Leroy, Véronique Loustaud-Ratti, Philippe Mathurin, Julie Chas, Caroline Jezequel, Sophie Métivier, Jérôme Dumortier, Jean-Pierre Arpurt, Tarik Asselah, Bruno Roche, Antonia Le Gruyer, Marc-Antoine Valantin, Caroline Scholtès, Emmanuel Gordien, Christelle Tual, Amel Kortebi, Fatoumata Coulibaly, Eric Rosenthal, Miroslava Subic-Levrero, Dominique Roulot, Fabien Zoulim, François Raffi, Laurent Alric, Patrick Miailhes, Albert Tran, Christiane Stern, Xavier Causse, Simona Tripon, Ghassan Riachi, Olivier Chazouillères, Armando Abergel, Louis d’Alteroche, Jérôme Gournay, Garance Lagadic, Patrizia Carrieri, Ségolène Brichler, Martin Siguier, Jessica Krause, Juliette Foucher, Souad Ben Ali, Magdalena Meszaros, Anne Varaut, Valérie Canva
Publikováno v:
JHEP Reports, Vol 6, Iss 8, Pp 101057- (2024)
Background & Aims: In France, bulevirtide (BLV) became available in September 2019 through an early access program to treat patients with HDV. The aim of this analysis was to evaluate the efficacy and safety of BLV in patients with HIV and HDV coinfe
Externí odkaz:
https://doaj.org/article/9c555ee813a44c469f08eabb29b34b1d
Autor:
Maria Paola Anolli, Elisabetta Degasperi, Colonia Sara Uceda Renteria, Dana Sambarino, Marta Borghi, Riccardo Perbellini, Alessandro Loglio, Caroline Scholtes, Floriana Facchetti, Mirella Fraquelli, Andrea Costantino, Ferruccio Ceriotti, Fabien Zoulim, Pietro Lampertico
Publikováno v:
Journal of Hepatology. 77:S880